Definition
A patent is a government-granted exclusive right awarded to an inventor, giving that inventor the legal authority to exclude others from making, using, selling, offering for sale, or importing the patented invention for a limited period — in the United States, generally twenty years from the filing date of the application. In exchange for this exclusivity, the inventor must publicly disclose the invention in sufficient detail that a person of ordinary skill in the relevant field could replicate it. This disclosure-for-exclusivity bargain is the constitutional and policy core of patent law.
The term operates across several distinct but related meanings in legal usage:
1. The grant itself. A patent is the legal instrument — the government document — conferring the exclusive right. This is what the U.S. Patent and Trademark Office (USPTO) issues upon finding that an invention meets the statutory requirements.
2. The underlying right. "Patents" as a category of intellectual property refers to the legal entitlement protecting new, useful, and non-obvious inventions and discoveries. This distinguishes patents from copyrights (which protect expression) and trademarks (which protect source-identifying marks).
3. Patents of land (historical). In older usage, "patent" referred more broadly to any open letter from a sovereign granting rights, privileges, or land. Land patents were common instruments in early American property law and colonial grants. This usage is largely obsolete in modern practice but appears frequently in historical legal sources.
---
Common Language
Wiktionary: Third-person singular simple present indicative of "patent" (as a verb — e.g., "she patents her inventions").
The everyday verb form — "to patent something" — reflects the common understanding of patents as something an inventor acquires through a process. The legal noun, however, carries substantial technical weight: a patent is not simply an award of credit or recognition of invention. It is a property right with defined scope, enforceability, and duration, bounded by claims language that determines what is and is not covered. The gap between popular understanding ("I invented it, so it's mine") and legal reality (scope is determined by the patent's written claims, which may be narrower or broader than the invention as colloquially understood) is a frequent source of confusion for non-specialist researchers.
---
Common Confusion
Patents are routinely conflated with other forms of intellectual property — particularly copyrights and trade secrets. The distinctions are not merely technical. Copyrights arise automatically upon creation of an original work and require no registration for protection; patents require affirmative government examination and grant. Trade secrets are protected by keeping information confidential; patents require disclosure. A researcher encountering historical disputes about "rights to an invention" should not assume the applicable legal regime without examining whether the claim sounds in patent, trade secret, contract, or some combination.
Within patent law itself, the term "patent" as used in contracts and property sources — particularly in the phrase "patent ambiguity" (an ambiguity apparent on the face of a document) — is entirely unrelated to intellectual property. See the Contracts & Commercial Law Encyclopedia entry on ambiguity for this separate usage.
---
Core Elements
For a utility patent to issue under U.S. law, the invention must satisfy four foundational requirements:
Patentable subject matter: The invention must fall within a recognized statutory category — process, machine, manufacture, or composition of matter. Abstract ideas, laws of nature, and natural phenomena are excluded, a limitation that has generated substantial litigation particularly in software and biotechnology contexts.
Novelty: The invention must be new — not previously known or used by others in the relevant art before the inventor's priority date.
Non-obviousness: The invention must not have been obvious to a person of ordinary skill in the art at the time the invention was made, considering the differences between the claimed invention and prior art.
Utility: The invention must have a specific, substantial, and credible use.
These elements are all required. An invention that satisfies three but fails one will not receive a patent.
---
Recognized Forms
/SUBTYPES
Utility patents: The dominant category. Covers new and useful processes, machines, manufactures, and compositions of matter. When "patent" is used without qualification in modern legal materials, this is almost always what is meant.
Design patents: Protect the ornamental appearance of a functional article. Distinct from utility patents in scope, duration, and the legal tests applied to infringement.
Plant patents: Cover distinct and new varieties of asexually reproduced plants. Narrow in scope and rarely litigated relative to utility patents.
Provisional patent applications: Not patents themselves, but placeholder filings that establish a priority date while allowing the applicant twelve months to file a full non-provisional application. Appear frequently in patent prosecution records and due diligence materials.
---
Why It Matters in Research
Patent law is a field where corpus materials span radically different legal regimes, and timeline awareness is essential. The America Invents Act (AIA) of 2011 shifted the United States from a first-to-invent system to a first-inventor-to-file system, affecting novelty analysis, prior art definitions, and inter partes proceedings. Materials predating 2011 apply a fundamentally different framework. Researchers analyzing pre-AIA disputes — or tracing the evolution of a patent family — must be careful not to apply modern standards retroactively.
Pharmaceutical patent research requires additional care. The Hatch-Waxman Act (1984) created a specialized litigation framework governing generic drug entry, Orange Book listings, and thirty-month stays. This regime has its own vocabulary (paragraph IV certifications, ANDA litigation, authorized generics) that does not appear in general patent doctrine sources. The Law Mind IP Encyclopedia entry on Hatch-Waxman is the recommended starting point for this area.
Historical sources — including Bouvier's and older treatises — use "patent" in both the intellectual property sense and the land grant sense. Context will usually distinguish them, but researchers working in early American property law, colonial land records, or pre-Civil War commercial disputes should not assume the IP meaning.
The claims language in a patent document controls infringement analysis. Researchers who read only the specification or abstract of a patent — without reading the claims — will systematically misunderstand what the patent actually covers. This is among the most common errors in non-specialist patent research.
---
Historical Dictionary Support
The Bouvier's entry supplied for this term does not address patents in the intellectual property sense. The entry provided — referencing "plan, scheme, or intention carried into effect" — corresponds to a separate Bouvier's entry for a different term entirely (likely "design" in the criminal law context, given the indictment reference). This is a source indexing anomaly, not a Bouvier's definition of patents.
Bouvier's actual treatment of patents in its various editions covers both letters patent generally (the sovereign grant) and patents for invention specifically, reflecting the dual historical usage. The intellectual property meaning was well-established in American law by the time of Bouvier's early editions, rooted in the Patent Act of 1790 and the constitutional grant of power to Congress to "promote the Progress of Science and useful Arts." Historical dictionaries of the nineteenth century tend to treat patents in the land grant sense as the primary meaning, with patent-for-invention as a specific application — a weighting that reverses in modern usage.
What historical sources uniformly miss: the modern claim-centered structure of patent law, the non-obviousness requirement (formalized in Graham v. John Deere Co., 1966), the AIA's structural reforms, and the specialized pharmaceutical patent regime. Researchers relying on historical dictionary support for modern patent analysis will find those sources useful for foundational concepts and terminology but insufficient for any issue arising from twentieth- or twenty-first-century doctrine.
---
Jurisdictional Note
Patent law in the United States is exclusively federal. State law cannot create or govern patent rights. The U.S. Court of Appeals for the Federal Circuit has exclusive appellate jurisdiction over patent cases, giving U.S. patent law a degree of uniformity not found in most other areas of federal law. International patent protection requires separate filings in each jurisdiction or use of treaty mechanisms such as the Patent Cooperation Treaty (PCT). A U.S. patent confers no rights outside the United States.
---
Encyclopedia Cross-Reference
Patent Law — Overview, History, and the Patent Act (35 USC) (The Law Mind Intellectual Property Encyclopedia) — foundational reference for all patent research; covers statutory requirements, prosecution, and enforcement framework.
The Hatch-Waxman Act and Pharmaceutical Patent Litigation (The Law Mind Intellectual Property Encyclopedia) — essential for any research touching pharmaceutical patents, generic drug entry, or ANDA litigation.
Interpretation — Ambiguity (Patent vs. Latent) and Contra Proferentem (The Law Mind Contracts & Commercial Law Encyclopedia) — for the distinct contract law usage of "patent" as a modifier meaning "apparent on the face of the document."
---